vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and HCI Group, Inc. (HCI). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $242.9M, roughly 1.4× HCI Group, Inc.). HCI Group, Inc. runs the higher net margin — 35.0% vs 4.0%, a 31.0% gap on every dollar of revenue. On growth, HCI Group, Inc. posted the faster year-over-year revenue change (12.2% vs 2.2%).
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
HCI Equity Partners is a Washington, DC–based private equity firm with an additional office in Chicago, Illinois.
GRDN vs HCI — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $336.6M | $242.9M |
| Net Profit | $13.5M | $85.0M |
| Gross Margin | 22.7% | — |
| Operating Margin | 5.3% | — |
| Net Margin | 4.0% | 35.0% |
| Revenue YoY | 2.2% | 12.2% |
| Net Profit YoY | 46.1% | 14.6% |
| EPS (diluted) | $0.21 | $5.45 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.6M | $242.9M | ||
| Q4 25 | $397.6M | $246.2M | ||
| Q3 25 | $377.4M | $216.3M | ||
| Q2 25 | $344.3M | $221.9M | ||
| Q1 25 | $329.3M | $216.4M | ||
| Q4 24 | — | $161.9M | ||
| Q3 24 | $314.4M | $175.3M | ||
| Q2 24 | — | $206.2M |
| Q1 26 | $13.5M | $85.0M | ||
| Q4 25 | $20.9M | $97.7M | ||
| Q3 25 | $9.8M | $65.5M | ||
| Q2 25 | $9.0M | $66.2M | ||
| Q1 25 | $9.4M | $69.7M | ||
| Q4 24 | — | $2.6M | ||
| Q3 24 | $-122.0M | $5.7M | ||
| Q2 24 | — | $54.1M |
| Q1 26 | 22.7% | — | ||
| Q4 25 | 21.5% | — | ||
| Q3 25 | 19.8% | — | ||
| Q2 25 | 19.8% | — | ||
| Q1 25 | 19.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 19.4% | — | ||
| Q2 24 | — | — |
| Q1 26 | 5.3% | — | ||
| Q4 25 | 7.7% | 58.5% | ||
| Q3 25 | 4.3% | 41.9% | ||
| Q2 25 | 3.7% | 42.5% | ||
| Q1 25 | 3.9% | 46.4% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | -33.3% | 8.0% | ||
| Q2 24 | — | 36.9% |
| Q1 26 | 4.0% | 35.0% | ||
| Q4 25 | 5.3% | 39.7% | ||
| Q3 25 | 2.6% | 30.3% | ||
| Q2 25 | 2.6% | 29.8% | ||
| Q1 25 | 2.9% | 32.2% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | -38.8% | 3.2% | ||
| Q2 24 | — | 26.2% |
| Q1 26 | $0.21 | $5.45 | ||
| Q4 25 | — | $7.29 | ||
| Q3 25 | — | $4.90 | ||
| Q2 25 | — | $5.18 | ||
| Q1 25 | — | $5.35 | ||
| Q4 24 | — | $0.32 | ||
| Q3 24 | — | $0.52 | ||
| Q2 24 | — | $4.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $64.9M | $1.0B |
| Total DebtLower is stronger | — | $31.7M |
| Stockholders' EquityBook value | $232.4M | $1.1B |
| Total Assets | $426.9M | $2.6B |
| Debt / EquityLower = less leverage | — | 0.03× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $64.9M | $1.0B | ||
| Q4 25 | $65.6M | $1.2B | ||
| Q3 25 | $36.5M | $987.9M | ||
| Q2 25 | $18.8M | $947.2M | ||
| Q1 25 | $14.0M | $754.5M | ||
| Q4 24 | — | $532.5M | ||
| Q3 24 | $37.2M | $518.8M | ||
| Q2 24 | — | $445.8M |
| Q1 26 | — | $31.7M | ||
| Q4 25 | $0 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $34.3M | — | ||
| Q2 24 | — | — |
| Q1 26 | $232.4M | $1.1B | ||
| Q4 25 | $217.9M | $1.0B | ||
| Q3 25 | $195.5M | $821.8M | ||
| Q2 25 | $179.7M | $758.6M | ||
| Q1 25 | $163.2M | $522.7M | ||
| Q4 24 | — | $453.3M | ||
| Q3 24 | $133.9M | $455.3M | ||
| Q2 24 | — | $447.3M |
| Q1 26 | $426.9M | $2.6B | ||
| Q4 25 | $412.7M | $2.5B | ||
| Q3 25 | $390.0M | $2.3B | ||
| Q2 25 | $356.3M | $2.4B | ||
| Q1 25 | $334.0M | $2.3B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | $348.0M | $2.0B | ||
| Q2 24 | — | $1.9B |
| Q1 26 | — | 0.03× | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 0.45× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $6.1M | — | ||
| Q4 25 | $34.6M | $444.4M | ||
| Q3 25 | $28.2M | $26.7M | ||
| Q2 25 | $19.9M | $145.0M | ||
| Q1 25 | $17.6M | $162.0M | ||
| Q4 24 | — | $331.8M | ||
| Q3 24 | — | $104.1M | ||
| Q2 24 | — | $-29.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $440.8M | ||
| Q3 25 | $24.2M | $25.9M | ||
| Q2 25 | — | $144.5M | ||
| Q1 25 | — | $160.3M | ||
| Q4 24 | — | $327.8M | ||
| Q3 24 | — | $103.2M | ||
| Q2 24 | — | $-30.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 179.0% | ||
| Q3 25 | 6.4% | 12.0% | ||
| Q2 25 | — | 65.1% | ||
| Q1 25 | — | 74.1% | ||
| Q4 24 | — | 202.5% | ||
| Q3 24 | — | 58.9% | ||
| Q2 24 | — | -14.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.5% | ||
| Q3 25 | 1.1% | 0.4% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.5% |
| Q1 26 | 0.45× | — | ||
| Q4 25 | 1.65× | 4.55× | ||
| Q3 25 | 2.87× | 0.41× | ||
| Q2 25 | 2.21× | 2.19× | ||
| Q1 25 | 1.86× | 2.32× | ||
| Q4 24 | — | 128.41× | ||
| Q3 24 | — | 18.33× | ||
| Q2 24 | — | -0.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
